- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Posterior Cross Bite in Singapore
Total 796 results
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Zeria PharmaceuticalCompletedCervical CancerJapan, Korea, Republic of, Malaysia, Singapore, Taiwan, Thailand, Vietnam
-
National Cancer Centre, SingaporeSingapore General HospitalRecruitingNon-Small Cell Lung Cancer | Lung CancerThailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
Pierre Fabre MedicamentCompletedMalignant Neoplasm of BreastChina, Taiwan, Singapore
-
Cullinan Oncology, LLCNational Cancer Institute (NCI)TerminatedNasopharyngeal Carcinoma | Nasopharyngeal CancerFrance, Singapore, United States, China, Hong Kong
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
Shanghai Proton and Heavy Ion CenterFudan University; West China Hospital; Tongji Hospital; Peking University Cancer... and other collaboratorsUnknownNasopharyngeal CarcinomaChina, Taiwan, Singapore
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsAustralia, Singapore, Netherlands
-
Taiho Pharmaceutical Co., Ltd.TerminatedHead and Neck CancerUnited States, Hong Kong, Singapore, Taiwan
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
BayerCompletedLiver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.Carcinoma | Liver Neoplasms | Adenoma | Liver AbscessUnited States, Japan, Singapore, Taiwan, Italy
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsCompletedEsophageal Cancer | Triple Negative Breast Cancer | Head & Neck CancerFrance, Singapore, Italy, Japan, United States, Spain
-
Trans Tasman Radiation Oncology GroupCompletedMetastatic Non Small Cell Lung CancerSingapore, Australia
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
BayerCompletedProstatic NeoplasmsChina, Singapore, Taiwan, Korea, Republic of
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States, Singapore, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Squamous Cell Carcinoma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the NasopharynxUnited States, Singapore, China
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerSingapore, Bangladesh, Thailand, Vietnam, Philippines, Indonesia, Korea, Republic of, Myanmar, New Zealand, Taiwan
-
BiogenCompletedHepatocellular CarcinomaUnited States, Singapore, Taiwan, United Kingdom
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Singapore
-
PfizerTerminatedPancreatic CancerBelgium, United States, Singapore
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Neoplasms | Non-Small-Cell Lung Carcinoma | Other Solid TumorsSpain, Germany, Singapore, Switzerland, Japan, United States
-
National Cancer Center, JapanPfizer; Korean Cancer Study GroupActive, not recruitingBreast NeoplasmsKorea, Republic of, Singapore, Japan, Taiwan
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
ASLAN PharmaceuticalsCompletedGastric CancerEstonia, Hong Kong, Korea, Republic of, Lithuania, Malaysia, Singapore, Taiwan, Thailand
-
National Cancer Institute (NCI)CompletedRecurrent Small Cell Lung CarcinomaUnited States, Singapore
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Singapore, Belgium, Malaysia, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
BayerTerminatedCarcinoma, Non-Small-Cell LungChina, Taiwan, Singapore, Thailand, Korea, Republic of, India
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Merck Sharp & Dohme LLCCompletedNeoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, New Zealand, Singapore, Taiwan
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
Boston Scientific CorporationCompletedBiliary Stricture | Periampullary Tumor | Biliary Obstruction Due to Common Bile Duct Stone | HemobiliaHong Kong, Korea, Republic of, Thailand, Australia, Saudi Arabia, Japan, India, Pakistan, Singapore, South Africa
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia